OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country
Nathalie Goutté, Philippe Sogni, Noelle Bendersky, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 3, pp. 537-544
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 293

Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 284-293
Open Access | Times Cited: 289

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 279

Inequities in primary liver cancer in Europe: The state of play
Loreta A. Kondili, Jeffrey V. Lazarus, Peter Jepsen, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 645-660
Open Access | Times Cited: 21

Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy
Lan Zheng, Chang'e Li, Xiaoting Huang, et al.
Biomaterials (2019) Vol. 216, pp. 119220-119220
Closed Access | Times Cited: 105

The Theory and Practice of Pancreatic Surgery in France
Olivier Farges, Noelle Bendersky, Stéphanie Truant, et al.
Annals of Surgery (2017) Vol. 266, Iss. 5, pp. 797-804
Closed Access | Times Cited: 104

The oncologic burden of hepatitis C virus infection: A clinical perspective
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 5, pp. 411-431
Open Access | Times Cited: 98

Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020
Vincent Mallet, Nathanaël Beeker, Samir Bouam, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 848-855
Open Access | Times Cited: 66

Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 23

EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL
Mingang Pan, Muyu Luo, Lele Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 14

NELL2 suppresses epithelial-mesenchymal transition and induces ferroptosis via notch signaling pathway in HCC
Shiqi Liu, Haomin Wu, Pengjie Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study
Charlotte Costentin, Abbas Mourad, Pierre Lahmek, et al.
Cancer (2018) Vol. 124, Iss. 9, pp. 1964-1972
Open Access | Times Cited: 65

The Epidemiology of Acute Liver Failure
Nina Weiler, Andreas Schlotmann, Andreas A. Schnitzbauer, et al.
Deutsches Ärzteblatt international (2020)
Open Access | Times Cited: 59

Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
Vincent Mallet, Lucia Parlati, Alessandro Martinino, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 265-274
Open Access | Times Cited: 44

Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness
Pegah Golabi, Isakov Va, Zobair M. Younossi
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 173-186
Closed Access | Times Cited: 20

Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres
Christelle Bouvry, Xavier Palard, Julien Edeline, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 55

Hepatocellular carcinoma in Australia 1982‐2014: Increasing incidence and improving survival
M. Christopher Wallace, David B. Preen, Mark W. Short, et al.
Liver International (2018) Vol. 39, Iss. 3, pp. 522-530
Closed Access | Times Cited: 52

Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
Sumeet K. Asrani, Marwan Ghabril, Alexander Kuo, et al.
Hepatology (2021) Vol. 75, Iss. 5, pp. 1289-1299
Open Access | Times Cited: 36

Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
Philippe Icard, Luca Simula, Zherui Wu, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100790-100790
Open Access | Times Cited: 36

Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
Clémence M. Canivet, Jérôme Boursier
Diagnostics (2022) Vol. 13, Iss. 1, pp. 91-91
Open Access | Times Cited: 25

Reduced survival for rural patients with hepatocellular carcinoma within a tertiary hospital network: treatment equality is not enough
Andrew R. Chin, Ali Galalah Mostafa Ismail, Weijun Fan, et al.
Internal Medicine Journal (2025)
Closed Access

Page 1 - Next Page

Scroll to top